Adding Facebook buttons and widgets to your site will allow others to 'Like', 'Recommend' and share information from your website with others easily and will help direct traffic to your site passively.
The 'Like Button' allows you to place the little thumbs up sign with the counter on your site to hopefully get an idea of how many of your visitors liked the article or post. This can come in very handy if you are trying to get integrate your site with your social media.
You embed the 'Like Button' on your website using the code Facebook provides. You can set up either 'Like' or 'Recommend' and when your users click the button, the counter will register the vote and increase the count by one. Their news feed on Facebook will also update with a link to your site indicating the viewer clicked 'Like'.
When using social media with your website, it's important to make the connections easy and effortless to follow so that your site members or visitors will have no problems recommending your site to others and gain dedicated followers or site members. Click here for more information about adding Facebook 'Like' to your website.
Sunday, October 31, 2010
A Volunteer Opportunity for MS Research
Hello multiple sclerosis (MS) Community! Quincy Bioscience is a research based biotech company studying the benefits of apoaequorin for individuals with MS. We’re now enrolling for a randomized, double-blind, placebo controlled trial measuring the effect of apoaequorin dietary supplement on quality of life measures and expectations with regard to aging in participants with MS. We'll send you free product that may help symptoms of MS. All you need to do is fill out a monthly survey tracking improvement. Learn more at www.hopetrials.com. Or, if you'd like to ask a specific question, please call our research team at (608) 827-8099.
Primary Outcome Measure Changes in ratings for Multiple Sclerosis specific quality of life survey based instruments including MSQOL-54, Modified Fatigue Impact Scale (MFIS), and MSIS-29 over six months.
Rationale
The World Health Organization estimates approximately 2.5 million people have multiple sclerosis (MS) worldwide and 500,000 in the United States. MS is a chronic, degenerative, inflammatory disorder that affects nerves in the brain and spinal cord. The nerve cell’s inability to regulate calcium ions is a key component of cellular dysfunction and subsequent cell death which may contribute to demyelination. The cause of calcium dysregulation in MS is unknown, however, there is some research which suggests that a gene mutation in MS patients causes excessively high levels of intracellular calcium in nerve cells which leads to activated T cells triggering an over stimulated immune response.
Apoaequorin is a naturally-occurring calcium-binding protein and is very similar to endogenous proteins which have been shown to deplete with age. In laboratory experiments conducted at the University of Wisconsin-Milwaukee, apoaequorin proved highly neuroprotective. In human trials of generally healthy adults, apoaequorin has shown to help cognition, sleep, mood, and other quality of life parameters. Apoaequorin is a safe non-toxic oral supplement which has been available for 3 years.
Apoaequorin is a naturally-occurring calcium-binding protein and is very similar to endogenous proteins which have been shown to deplete with age. In laboratory experiments conducted at the University of Wisconsin-Milwaukee, apoaequorin proved highly neuroprotective. In human trials of generally healthy adults, apoaequorin has shown to help cognition, sleep, mood, and other quality of life parameters. Apoaequorin is a safe non-toxic oral supplement which has been available for 3 years.
Case reports gathered from apoaequorin dietary supplement users with MS have seen improvements in some MS symptoms.
Inclusion Criteria:
1. Diagnosis of Multiple Sclerosis
2. Ability to complete study questionnaires
3. Ability to connect to the internet and possess an email address
Exclusion Criteria:
1. Any disability acquired from trauma or another illness that could interfere with the evaluation of disability due to MS.
2. Major systemic disease that cannot be treated or adequately controlled by therapy.
3. Subject is unable to comply with dosing instructions.
4. Psychiatric or cognitive conditions that compromise the subject’s ability to understand patient information, to give informed consent, to comply with the trial protocol, or to complete the study.
5. Subject who, in the investigator’s opinion, will not comply with the study procedure.
6. Ongoing pregnancy or an intent to become pregnant during the study
Locations The study can be participated in from anywhere throughout the United States. Surveys will be sent via the internet.
Copyright Quincy Bioscience
Subscribe to:
Posts (Atom)